Study Highlights: Women who have lost at least 10 pounds, only to regain the weight within a year, are more likely to have a poor score on the American Heart Association’s - Life’s Simple 7, a measure of how well people control important heart disease risk factors. The more episodes of yo-yo dieting women report, the worse they score on Life’s Simple 7. In addition to achieving a healthy weight, maintaining a consistent body weight may be important for lowering heart disease risk. Embargoed until 3 p.m. CT/ 4 p.m. ET, Thursday, March 7, 2019 (NewMediaWire) - March 07, 2019 - HOUSTON - Yo-yo dieting may make it harder for women to control a variety of heart disease risk factors, according to preliminary research presented at the American Heart Association’s Epidemiology and Prevention | Lifestyle and Cardiometabolic Health Scientific Sessions 2019, a premier global exchange of the latest advances in population-based cardiovascular science for researchers and clinicians. “Achieving a healthy weight is generally recommended as heart healthy but maintaining weight loss is difficult and fluctuations in weight may make it harder to achieve ideal cardiovascular health,” said Brooke Aggarwal, Ed.D., M.S., senior author of the study and assistant professor of medical sciences at Columbia University Vagelos College of Physicians and Surgeons in New York. Investigators studied 485 women (average age 37 years, 61 percent racial/ethnic minorities, average body mass index 26, in the overweight range) participating in the American Heart Association’s Go Red for Women Strategically Focused Research Network at Columbia University in New York City. Women reported how many times (other than during pregnancies) they had lost at least 10 pounds, only to regain the weight within a year. They were assessed on American Heart Association’s - Life’s Simple 7, a measure of how well people control important heart disease risk factors (including body mass index, cholesterol, blood pressure, blood sugar, smoking, physical activity and diet). Most of the women (73 percent) reported at least one episode of yo-yo weight loss, with a range of zero to 20 episodes. Researchers found that women with one or more episodes of yo-yo weight loss were: 82 percent less likely to have an optimal body mass index (between 18.5 and 25, neither underweight or overweight for their height); and 51 percent less likely to be rated as moderate, and 65 percent less likely to be rated as optimal overall on Life’s Simple 7. The more episodes of weight cycling women reported, the poorer they scored on Life’s Simple 7, according to the researchers. The detrimental impact of weight-cycling on the overall Life’s Simple 7 score was most striking in women who had never been pregnant. “The women without a pregnancy history were likely younger and might be those who started weight-cycling at an earlier age. We need to identify critical periods for the effect of weight fluctuation on heart disease risk over the life course to find out whether it is worse when women start on a dieting roller-coaster at an early age,” said Aggarwal. The study is limited in not differentiating unintentional from intentional weight loss, and in being based on self-reported data and measures taken at a single time. Aggarwal stressed that the team cannot currently tease apart whether yo-yo dieting has adverse effects on Life’s Simple 7 factors or rather that those who don’t adhere to guidance on Life’s Simple 7 have a harder time maintaining low weight and end up yo-yo dieting more frequently. The study’s results in women may not be generalizable to men. “We hope to extend the study five to ten years to confirm these results and look at long-term effects,” Aggarwal said. “However, there has been prior research that showed similar results in men, with those who weight-cycled having twice the risk of cardiovascular death in middle age.” Co-authors are: Stephanie S. Byun, M.S.; Natalie A. Bello, M.D., M.P.H.; Ming Liao, M.S.; and Nour Makarem, Ph.D., M.S. Author disclosures are on the abstract. The American ...
Study Highlights: Higher social support and a sense of purpose in life are associated with higher cognitive functioning in middle-aged and older Hispanics/Latinos. Loneliness has a negative relationship with cognitive function. Strengthening social resources might improve the health of Hispanics/Latinos as they age, perhaps lowering the risk of dementia. Embargoed until 3 p.m. CT/ 4 p.m., Thursday, March 7, 2019 (NewMediaWire) - March 07, 2019 - HOUSTON - Higher social support and having a sense of purpose in life are each associated with higher cognitive functioning in middle-aged and older Hispanics/Latinos, while loneliness has a detrimental effect on cognition, according to preliminary research presented at the American Heart Association’s Epidemiology and Prevention | Lifestyle and Cardiometabolic Health Scientific Sessions 2019, a premier global exchange of the latest advances in population-based cardiovascular science for researchers and clinicians. Previous studies have shown that psychological resources (such as optimism) and stressors (such as loneliness) are associated with cognitive functioning in non-Hispanic blacks and whites, but less is known about the role of these factors in Hispanics/Latinos. “Given the exponential increase in the Hispanic/Latino aging population, we need to consider tailored approaches to improve health. In this study, we are trying to identify key psychosocial resources in this population which could be used to improve their health as they get older,” said Mayra L. Estrella, Ph.D., M.P.H., lead author of the study and a research assistant professor at the Institute for Minority Health Research at the University of Illinois at Chicago. Participants included 1,572 women and 1,200 men between 45 and 74 years of age (average 56 years) who are part of the Sociocultural Ancillary Study of the Hispanic Community Health Study/Study of Latinos, a multi-center research project aimed at identifying factors that play a protective or harmful role in the health of Hispanics. Each participant reported on a variety of psychosocial factors, and they were tested on various cognitive skills and overall cognitive functioning. The researchers found: Higher scores on ethnic identity, life engagement and social support were associated with higher cognitive functioning; Higher scores on loneliness and familism (the extent to which the needs and interests of the family are more important that the individual’s needs) were associated with lower cognitive functioning. Higher perceived ethnic discrimination, which has been associated with lower cognitive functioning in studies of African Americans, was not associated with cognitive function in this group. “Life engagement – having a sense of purpose in life and engaging in activities that are personally valued – as well as social support from family and friends, were associated with better cognitive functioning, regardless of people’s age, sex, income, education, symptoms of depression or heart disease risk factors. Tapping into these psychosocial resources while minimizing stressors may provide effective strategies for improving cognitive function with age,” Estrella said. The researchers were surprised to find that familism, an important component of Hispanic/Latino culture which is usually seen as a positive personal resource, was associated with lower cognitive functioning. “Our results suggest that putting family interests ahead of your own may be a psychosocial stressor among middle-aged and older Hispanics and Latinos. One potential reason is that families with limited social and economic resources may places stressful demands on individuals, such as being a caretaker or helping economically,” said Estrella. While the current study did not focus on disease states such as Alzheimer’s disease and other dementias, finding potentially modifiable ways to improve cognitive function with age may help reduce the high burden of dementia among older Hispanics/Latinos living in the United States, according to the researchers. The investigators are conducting a ...
Study Highlight: Eating olive oil more frequently among healthy obese adults was associated with less platelet activity in the blood. Platelets are blood cell fragments that stick together to form clots. Embargoed until 3 p.m. CT/4 p.m. ET, Thursday., March 7, 2019 (NewMediaWire) - March 07, 2019 - HOUSTON - In a group of healthy, but obese adults, eating olive oil at least once a week was associated with less platelet activity in the blood, which may reduce the tendency of blood to clot and block blood flow, according to preliminary research presented at the American Heart Association’s Epidemiology and Prevention | Lifestyle and Cardiometabolic Health Scientific Sessions 2019, a premier global exchange of the latest advances in population-based cardiovascular science for researchers and clinicians. Platelets are blood cell fragments that stick together and form clumps and clots when they are activated. They contribute to the buildup of artery-clogging plaque, known as atherosclerosis, the condition which underlies most heart attacks and strokes, according to lead study author Sean P. Heffron, M.D., M.S., M.Sc., assistant professor at NYU School of Medicine and the NYU Center for the Prevention of Cardiovascular Disease in New York, New York. Using food frequency surveys, researchers determined how often 63 obese, nonsmoking, non-diabetic study participants ate olive oil. The participants’ average age was 32.2 years and their average body mass index (BMI) was 44.1. Obesity is defined as having a body mass index – a measure of body weight – over 30. Researchers found that those who ate olive oil at least once a week had lower platelet activation than participants whose ate it oil less often, and that the lowest levels of platelet aggregation were observed among those who ate olive oil more frequently. “People who are obese are at increased risk of having a heart attack, stroke or other cardiovascular event, even if they don’t have diabetes or other obesity-associated conditions. Our study suggests that choosing to eat olive oil may have the potential to help modify that risk, potentially lowering an obese person’s threat of having a heart attack or stroke,” Heffron said. “To our knowledge, this is the first study to assess the effects of dietary composition, olive oil specifically, on platelet function in obese patients,” said co-author Ruina Zhang, B.S., an NYU medical student. Some limitations of the study are that it relied on questionnaires completed by the participants; it measured how often they ate olive oil, but not how much olive oil they ate; and because it was observational the study could not prove that eating olive oil will reduce platelet activation in obese adults. Co-authors are: Ruina Zhang, A.B.; Manish Parikh, M.D., M.S.; Christine J. Ren-Fielding, M.D.; Sally M. Vanegas, Ph.D.; Melanie R. Jay, M.D., M.S.; Karry Calderon, A.B.; Edward A. Fisher, M.D., Ph.D., M.P.H.; and Jeffrey S. Berger, M.D., M.S. Author disclosures are on the abstract. The National Institutes of Health funded the study. Additional Resources: Multimedia including AHA volunteer expert, Linda Van Horn, PhD, RDN, FAHA, offers perspective (via audio/photo). Download and transcript available on the right side of the release link https://newsroom.heart.org/news/eating-olive-oil-once-a-week-may-be-associated-with-making-blood-less-likely-to-clot-in-obese-people?preview=e28fb9b9b48136de11a0336284e6c5ac Spanish release Managing Your Weight Mediterranean diet with virgin olive oil may be recipe for ‘good’ cholesterol For more news from AHA EPI Lifestyle Conference 2019, follow us on @HeartNewsTwitter #EPILifestyle19. Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device ...
Fountain Valley, CA, March 07, 2019 (NewMediaWire) -- Triad Pro Innovators, Inc. (OTC Pink; TPII): Triad Pro is proud to announce a new breakthrough in its eCell energy storage technology. Triad Pro’s new power supply design, which just passed its final development milestone, can now provide access of up to 90% of the stored energy in its eCell, as opposed to common battery storage systems, which can only access 30-35% of stored energy. The Triad Pro eCell uses static dynamic storage elements, as opposed to the liquids used in a chemical battery. In off-grid scenarios and applications energy storage using traditional battery systems has many shortfalls: 1) they take too long to charge; 2) have limited variability at discharge; 3) require maintenance; 4) need to be replaced often due to limited charge/discharge cycles; 5) suffer from drastically reduced performance in extreme temperatures; 6) are routinely overbuilt to compensate for these weaknesses, or are not used at all. The newly developed Triad Pro power supply provides our storage system with tremendous operational flexibility. Using our propriety hardware and software solution, our eCell can be configured to store energy at a rate limited only by the network providing it, and then release that energy in a regulated way based upon the application, which allows for flexibility unknown in current chemical battery-based storage systems.For additional information about Triad Pro Innovators visit the website at: triadproinc.com Forward-looking Statements: This release contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements, which contain words such as “expect”, “believe” or “plan”, by their nature address matters that are, to different degrees, uncertain. The information in this release is provided only as of the date of this release, and we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events, except as required by law.Murray Goldenberg 3108902209 m.gol@verizon.net
Chatsworth, CA - (NewMediaWire) - March 07, 2019 - Cavitation Technologies, Inc. (OTCQB: CVAT) (BERLIN: WTC) is pleased to announce that it received 2 new purchase orders from Desmet Ballestra Group, a strategic partner and licensee of Cavitation Technologies, Inc.’s vegetable oil refining technology since 2010.The Nano Reactor® systems will be installed for use in a vegetable oil refinery in Mexico at both ~200 and 400 metric tonnes per day (MTPD). The Company anticipates receiving $200,000 in the aggregate from this order and expects to record the revenue in the third quarter of Fiscal 2019.Igor Gorodnitsky, President of CTi, said, “We are delighted to receive not one, but two more purchase orders from our strategic partner, Desmet Ballestra. This will be the 16th and 17th installation in North and South America combined and the 3rd and 4th in Mexico.”About CTiFounded in 2007, the company designs and manufactures innovative flow-through devices and systems, as well as develops processing technologies for use in edible oil refining, renewable fuel production, water treatment, and alcoholic beverage enhancement. The company's patented Nano Reactor® systems and various technologies have over 30 patents issued and filed both domestically and abroad. http://www.ctinanotech.com/Follow us on Twitter for real time updates: https://twitter.com/CavitationTech Like us on Facebook to receive live feeds updates: https://www.facebook.com/ctinanotech Check us out on LinkedIn: https://www.linkedin.com/company/cavitation-technologiesAbout Desmet Ballestra GroupThe Desmet Ballestra Group provides engineering and supply of plants and equipment for the following industries worldwide:Oils and Fats and Animal FeedDetergents, Surfactants and related ChemicalsOleochemical and BiodieselDesmet Ballestra's R&D Team is composed of professionals specialized in Oils and Fats, oleochemicals and chemical processes, using the most comprehensive set of technological resources and equipment. Controlled by Financière DSBG, a holding company based in Paris, France, the Desmet Ballestra Group is present in all major market areas of the world through its integrated business units located in Northern and Central America (USA, Mexico), South America (Argentina, Brazil, Colombia), Asia & Far East (PR China, Singapore, Malaysia), India and Europe (Belgium, Turkey, Russia, Spain). http://www.desmetballestra.com/Forward Looking StatementThis release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases forward-looking statements can be identified by terminology such as "may," "should," "potential," "continue," "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions, and include statements regarding the anticipated installation and the timing of the installation, our intent to continue to focus on research and development, marketing and sales of our unique technology, our belief that our company is positioned for accelerated growth and the expected efforts to be made to enhance our shareholder's value. These forward-looking statements are based largely on the Company's expectations and are subject to a number of risks and uncertainties, certain of which are beyond the Company's control. Actual results could differ materially from these forward looking statements as a result of a variety of factors including, among others, the state of the economy, the competitive environment and our ability to perform the installation as anticipated and other factors described in our most recent Form 10-K and our other filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. In light of these risks and uncertainties there can be no assurances that the forward looking statements contained in this press release will in fact transpire or prove to be accurate. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on ...
Fort Lauderdale, FL - (NewMediaWire) - March 7, 2019 - MediXall Group Inc., (OTCQB: MDXL), division of MediXall.com, a technology and innovation-driven organization focused on transforming the patient-provider experience, is pleased to announce today the company’s expansion into the eye care arena with the appointment of Dr. Howard J. Braverman to the MediXall Advisory Board.Dr. Braverman’ s distinguished career of more than 40 years in the eye care industry includes practicing optometry in Florida for more than 28 years, as well as serving as the President of the American Optometric Association. Most notably, he was the National Vision Director for Humana’s Employer Group Segment. Dr. Braverman will provide guidance and support on strategic initiatives, as well as homing in on the patient-provider experience, as he has years of industry experience working directly with patients.Patients today expect seamless and personalized experiences when it comes to their healthcare, which is why MediXall developed a new tool for physicians to engage their patients with the level of price transparency and digital convenience that they have come to expect in every other aspect of their lives. With Braverman’s direct patient-provider experience, he will guide MediXall on optimizing the new MediXall Patient Experience, so that it integrates patient relationship management/commerce with digital marketing solutions to help grow their practice, improve office efficiency, and optimize appointment capacity.“Dr. Braverman is well-known and respected throughout the healthcare industry and is an outstanding business person with strategic vision and excellent execution skills,” said Michael Swartz, President of MediXall. “We're fortunate to have Dr. Braverman on our advisory board to assist with the critical areas of identifying and pursuing key strategies to help facilitate MediXall’s roll-out into the Vision space. His impressive 40-year career in optometry, coupled with his experience serving in various leadership capacities within the healthcare industry, will be a valuable resource for our team as we continue to expand our services and streamline efficiency with our platform overall.”Dr. Braverman’s previous experience included serving as President of The Vision Division of CompBenefits, Inc. He was also the Chief Executive Officer of Ultimate Optical, a wholesale prescription optical laboratory that was part of CompBenefits’ family of companies.Dr. Braverman has also served in a leadership capacity as part of various board and professional organizations. Most notably, he was the President of the American Optometric Association from 2000 –2001. He was also President of the Southern Council of Optometrists in 1993 and named “Optometrist of the South” in 1998. In addition, he served as the Chairman of the Florida State Board of Optometry, has been a member of the Florida Optometric Association, and has served as a trustee of Nova Southeastern University. He is currently a member of the Board of Governors of the Health Professions of Nova Southeastern University.“As a leader in the eye care profession, I am looking forward to working with the MediXall Leadership team’s technology-driven innovations in the patient/ provider experience. MediXall’s digital innovations will be an invaluable aid to help optometrists improve their office efficiency, which in turn allows optometrists to improve the quality of care for patients that they serve every single day,” said Dr. Howard Braverman.As a member of the MediXall advisory board, Dr. Braverman will work closely with the MediXall leadership team to consult on business strategy and sales, marketing, and product plans, as well as identify additional market opportunities and new strategic partnerships for the company. Furthermore, he will provide strategic and tactical insights on finding new ways to help address patients’ vision wellness needs, drive more patients to providers, improve provider growth and profitability, and help develop an eye care marketing campaign.For more information, please ...
Anticipated Revenues Growing at a Staggering PaceNewport Beach, CA - (NewMediaWire) - March 07, 2019 - M Line Holdings, Inc. (OTC Pink: MLHC; "M Line" or the “Company”).After distributing our shareholder letter on February 26, 2019, we wanted to continue to provide more details about the progress of the individual subsidiaries. Our first update is about the Caravel Group. They are having a fantastic first quarter of 2019. Negotiations are in the final stages with many large US retail chains to put our VEA™ branded drinks (VEA™ Proactive Hydration and VEA™ caffeinated sparkling water) on their shelves within the retailers shelf reset schedules. Additionally, we continue to be incredibly excited by our newly formulated TORQUE® Sugar Free Energy Drink and consumer chosen new TORQUE® Flavor line extension. All three brands, TORQUE® Energy Drink, TORQUE® Sugar Free and soon to be announced TORQUE® Flavor Line Extension are receiving very positive feedback from distributors and retailers. On the international stage we are also having great success. Caravel is in negotiations with international distribution partners for the VEA™ Brands and the TORQUE® Energy brands. Our distributor in Mexico is increasing their current purchase orders due to the excitement for the Caravel brands from Mexico’s key retailers.Our first orders of Lorenzo Caputo wine will be available for distribution later this month and we expect rapid growth once the wine brand appears on the TLC Channel, hot non-scripted show, Long Island Medium.Tony Anish, CEO of M Line, commented: “The growth in business that we are experiencing is far beyond what we expected for this year. The sales team at Caravel are doing an amazing job with our beverages. Tony continued: “I want to take this opportunity to again thank all our shareholders for believing in us. We recognize that the most important issue for shareholders is increased shareholder value. As management, we knew that it would take significant funds to build our group of companies and now, in an effort to achieve improved shareholder value, we have taken the following very important steps:I will be negotiating with our debt holders to freeze all dilution for an extended period of time. More details will be given next week.We will be announcing full details of the public company acquisition next week and we will consolidate its results with MLHC. This is not a spin-off but part of our growth.We will announce details next week of our plans to issue a dividend of a portion of the public company stock we acquire, subject to regulatory approval.The current and future prospects of MLHC has never looked brighter and because of the hard work of management and the support of our shareholders, we are now in the position to freeze dilutive measures to help increase the price of our shares”About M Line Holdings, Inc.M Line is a Holding Company. It controls subsidiaries involved in the Beverage Branding and Distribution industry that includes our branded drinks. In addition, M Line controls two subsidiaries in Florida in the Food and Beverage distribution business and M Line has now expanded into the Cannabis Industry with the acquisition of our C-Pod manufacturing business. M Line owns three restaurants and an event center in Arizona and land for development. M Line will continue with its business financing activities while looking for other opportunities in the Beverage, Distribution, hospitality and Cannabis industries as well as other prospects that make sense to management.Safe Harbor and Informational StatementThis press release may contain forward-looking information within the meaning of Section 21E of the Security Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statement of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company's financing plans; (ii) trends affecting the company's financial conditions or results of operations; (iii): the company's ...
DENVER, CO - (NewMediaWire) - March 07, 2019 - Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”, ”the Company”), an international adaptive healthcare solutions company, today announced that it has broken ground on its first Community Clinic and Dispensing Pharmacy for the treatment of diabetes in the Republic of Vanuatu. The Company held a groundbreaking event at 11:00 a.m. on March 5th in Erakor Village, Vanuatu where the Paramount Chief welcomed Phoenix Life officials, such as Global Head of Security and Transport, Former Police Commissioner John Taleo, Head of National Healthcare, Former Director of Port Vila Central Hospital, the Department of Curative & Hospital Services and Vanuatu’s Ministry of Health, Dr. Santus Wari, and Martin Tindall, Phoenix Life CEO and Founder.According to the International Diabetes Federation, 1 in 10 Vanuatu citizens are diagnosed with diabetes every year. This is why Denver-based Phoenix Life chose to tackle diabetes in The Republic of Vanuatu, with a focus on addressing the national diabetes epidemic with Phoenix Metabolic, a plant based pharmaceutical, extracted from the cannabis plant and designed to specifically manage diabetes and its complications. Phoenix Life intends to deliver programs to make diabetes healthcare more accessible and affordable for national healthcare system providers, such as governments in the developing and least developed nations. “We appreciate the work that Phoenix Life Sciences International is doing in the Republic of Vanuatu to create a solution for our diabetes epidemic using botanical medicine. We’re sorry we were unable to attend the groundbreaking at Erakor Village but we are very excited for the commencement of Phoenix Life’s national diabetes screening and management program in the upcoming months,” said Vanuatu Minister of Health Hon. Jack Norris Kalmet.At the event, Dr. Santus Wari gave a speech on the benefits of this clinic and stressed the importance of citizens participating in blood sugar testing to better understand their health. Phoenix Life CEO Martin Tindall explained the company’s plans to open a national network of Phoenix Life Community Clinics and Dispensing Pharmacies over the next year. Further, Tindall explained that Phoenix Life plans to conduct clinical trials in Vanuatu, to be overseen by leading endocrinologists from Australia and the United States. These double blind randomized clinical trials will be used to confirm the efficacy of Phoenix Metabolic as a treatment for diabetes as part of Phoenix Life’s global rollout strategy.Through this Community Clinic and future locations, Phoenix Life plans to increase healthcare infrastructure throughout the nation to promote better health and provide significant improvements in healthcare, initially in the field of diabetes management. Now at locations around the Island Nation and at the event, Phoenix Life offers complimentary blood sugar screenings to test for diabetes and pre-diabetes in the population. Approximately 400 people were screened at the event. Attendees were served a healthy lunch made of traditional Vanuatu cuisine (Island Kai Kai) and taught about ways to improve their health through clean eating habits. “Diabetes is a disease that affects millions across the globe and is near to my heart as my family, like so many others, has been affected by it,” said Martin Tindall, CEO of Phoenix Life Sciences International Limited. “The groundbreaking of our first Community Clinic and Dispensing Pharmacy for the treatment of diabetes is an exciting next step for Phoenix Life as we work diligently to carry out our mission of transforming international healthcare.”The clinic will be the first of a national network of Community Clinics and Dispensing Pharmacies for Phoenix Life and will feature examination rooms, analytical labs, a dispensing pharmacy and other services for the health of the local people. As Phoenix Life continues rolling out its screening program “Sik Suka ? Jekem Ia !”, and a national network of Community Clinics and Dispensing ...
Los Angeles, CA - (NewMediaWire) - March 07, 2019 - NUGL Inc. (OTC: NUGL) (the “Company”), a one-stop shop for all things cannabis through the intelligent connection of consumers and companies, is pleased to announce its promotional partnership with the National Cannabis Industry Association (NCIA). The National Cannabis Industry Association has been a leader in defending state and federal laws, representing business and industry growth, and one of the largest and most established organizations in the industry.“NCIA’s proven impact and support of the cannabis industry is unprecedented and a key factor in getting this community to where we are today. To say it is influential is a massive understatement,” stated Bob Waters, V.P. of Sales, NUGL Inc. “NUGL is all about helping businesses grow in the cannabis space. Working with and through the NCIA, who epitomizes the term ‘canna-business first,’ is a natural fit for NUGL and its affiliate media outlets. Together, we will be able to leverage our consumer and business traffic and reach to help promote the cannabis community as well as advance NCIA’s efforts to progress the cannabis industry and NUGL Inc. as a whole.”“We are proud of the work NUGL has done informing cannabis producers about issues and developments that are important to them, and excited to join them in raising the standard of cannabis media and education,” said Aaron Smith, executive director of the National Cannabis Industry Association. “With NUGL’s help, we will be able to get more producers involved with our policy reform efforts on behalf of the industry, while connecting them to even more businesses and consumers.”NUGL launched its social media platform Tuesday March 5, 2019. "We plan on a 30 day launch with both NUGL 1.0 and NUGL 2.0 running parallel with one another. The platform is too big and we have too much traffic so we want to play it safe,” stated Ryan Bartlette, CMO, NUGL. “We will be offering features daily and moving the business platform over to work seamlessly with the active user platform.”NUGL’s social media platform is the first of its kind, offering real time map locations for users and businesses. It provides the most robust networking platform in the social media space and looks to expand into the mainstream market. About NCIAThe National Cannabis Industry Association is representing nearly 2,000 member-businesses and tens-of-thousands of cannabis professionals. NCIA is leading the charge to protect legal cannabis businesses, defend our state laws, and advance federal policy reforms. Successful businesses are joining NCIA every day to become stronger, smarter, and more prosperous by working together to defend and expand the responsible cannabis industry. Visit: www.ncia.comAbout NUGLNUGL is the world’s first cannabis search app built for the people, by the people. Our goal is to build the most user-friendly app experience in the cannabis industry by listening to our users and giving them what they want. NUGL is the only cannabis search app that offers equal and unbiased search results. We don’t sell top-spot listings or fake reviews, so our data stays true. Use NUGL to search for genuine user-rated dispensaries, strains, doctors, lawyers, cannabis service providers, vape shops, hydro stores, brands and more. NUGL’s flexible web app has no geographic limitations and can rapidly connect cannabis companies, related vertical services and users. The NUGL iOS and Android app brings a powerful cannabis search tool within reach of anyone, anytime, anywhere with the ease of a smartphone.For more information and updates, visit one of the links below.Website: http://www.nugl.com/ Facebook: https://www.facebook.com/nuglapp/Instagram: https://www.instagram.com/nuglapp/Twitter: https://twitter.com/nuglapp/LinkedIn: https://www.linkedin.com/company/nuglapp/Newsletter: https://nugl.us16.list-manage.com/subscribe?u=219fe8bb6995a19827c9f36cb&id=dc46712578Forward-Looking StatementsCertain statements in this press release may be considered "forward-looking statements" within the meaning of the ...
(NewMediaWire) - March 07, 2019 - DALLAS - A California physician-scientist with expertise in cardiovascular genetics and multimodal imaging has been recognized with a $10,000 cash award from the American Heart Association, the world’s leading health and wellness organization focused on heart and brain health, and Amazon Web Services through their collaboration in data mining research powered by innovative cloud technology. Rima Arnaout, M.D., from the University of California, San Francisco, received the award for progress in her cloud-based technology research work in automating echocardiogram images to rapidly and accurately analyze the heart’s function. This could ultimately make it faster to diagnosis various cardiovascular conditions. Arnaout, an assistant professor in medicine (cardiology) and a member of the UCSF Institute for Computational Health Sciences, has a background in genetics, clinical research and programming, and is a practicing cardiologist board-certified in multi-modality cardiovascular imaging. She is the latest researcher to receive the award given as a cash incentive from the American Heart Association and Amazon Web Services through the Association’s Institute for Precision Cardiovascular Medicine – dedicated exclusively to advancing precision medicine in cardiovascular research. “These specialized grants are designed to accelerate cardiovascular research at the intersection of science and technology using big data to fast-track precision treatments for cardiovascular disease,” said Jennifer Hall, Ph.D., Chief of the Institute for Precision Cardiovascular Medicine. “The Institute is encouraging researchers like Dr. Arnaout to push scientific discovery and demonstrate the power of data science. We hope others will be inspired by Rima’s work.” Leveraging machine learning technology, American Heart Association/Amazon Web Services grant recipients are transforming a one-size-fits-all healthcare to improve health outcomes. Innovative cloud technology can potentially give physicians and cardiologists precision health tools to provide enhanced prevention and treatment solutions. All grant awardees use Amazon Web Services computational cloud credits to leverage the power of cloud computing, open data and new artificial intelligence and machine learning tools available through the American Heart Association Precision Medicine Platform™. The American Heart Association Precision Medicine Platform, powered by Amazon Web Services cloud technology, is becoming a central hub to the cardiovascular and stroke research community to access vast and diverse datasets to accelerate scientific discovery. ### The American Heart Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at https://www.heart.org/en/about-us/aha-financial-information. About the American Heart Association The American Heart Association is a leading force for a world of longer, healthier lives. With nearly a century of lifesaving work, the Dallas-based association is dedicated to ensuring equitable health for all. We are a trustworthy source empowering people to improve their heart health, brain health and well-being. We collaborate with numerous organizations and millions of volunteers to fund innovative research, advocate for stronger public health policies, and share lifesaving resources and information. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1. About the American Heart Association’s Institute for Precision Cardiovascular Medicine The American Heart Association's Institute for Precision Cardiovascular Medicine aims to advance the science and practice of personalized medicine to improve the cardiovascular health of individuals and ...
